WHC is still in active development. Read this to understand our approach.
depiction of PHLBKPHSAVXXEF-UHFFFAOYSA-N.svg
tripsit

trazodone

Verificar en tripsit

isomerdesign

Trazodone

Verificar en isomerdesign

pubchem

Trazodone

Verificar en pubchem

drugmap

Trazodone

Verificar en drugmap

wiki

Trazodone

Verificar en wiki

Data

InChI: InChI=1S/C19H22ClN5O/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25/h1-3,5-7,9,15H,4,8,10-14H2

Sinónimos: BPBio1_000248,DTXSID5045043, Desyrel Dividose,Oprea1_185901,TRAZODONE [VANDF],SBI-0051126.P003,2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one,1,2,4-Triazolo(4,3-a)pyridin-3(2H)-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-,, Trazodon,Trazodone (INN), Trazonil,AKOS015896423,Trazodone,KBioGR_001110,DB00656,NCGC00024405-03,794T935,BDBM50073444,BSPBio_003040, 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one,Trazodone free base,HSDB 7048, Trazodone (INN),Spectrum5_000974,2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)-[1,2,4]-triazolo[4,3-a]pyridin-3(2H)-one,AB00053648_16, Trazorel (TN), Trittico,KBio2_001904,2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,5-a]pyridin-3-one, Molipaxin (TN), Tradozone,CAS-25332-39-2,DivK1c_000196,NCGC00016035-06,KBio3_002540,SCHEMBL28167,AC-6778,2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one,FT-0658382,Trazodone [INN:BAN],KBio2_007040,1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one, 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-,Trazodonum [INN-Latin], Trazodil, Trazodonum [Latin],C07156,NCGC00016035-04,Desirel,8-[3-[4-(3-Chlorophenyl)piperazin-1-yl]propyl]-1,7,8-triazabicyclo[4.3.0]nona-2,4,6-trien-9-one hydrochloride,Spectrum3_001560,NCGC00016035-12,TRAZODONE [WHO-DD],19794-93-5 (free),Trittico (TN),2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-2H,3H-[1,2,4]triazolo[4,3-a]pyridin-3-one,KBio2_004472,2-(3-(4-(M-CHLOROPHENYL)-1-PIPERAZINYL)PROPYL)-S-TRIAZOLO(4,3-A)PYRIDIN-3(2H)-ONE,Q411457, Beneficat (TN),Trazonil,Trazalon, Trazodone Hcl, Trazodonum [INN-Latin],CCG-205233, Deprax (TN), 2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one,L000771,Trazodona [Spanish],KBioSS_001904, Sideril, Desyrel (TN),Oleptro,NCGC00016035-10, Trittico (TN), Thombran (TN),NINDS_000196,trazodone,Prestwick2_000292,Prestwick3_000292, 8-[3-[4-(3-Chlorophenyl)piperazin-1-yl]propyl]-1,7,8-triazabicyclo[4.3.0]nona-2,4,6-trien-9-one hydrochloride,s5857,Spectrum2_000854,Trazodonum [Latin],KBio1_000196,TRAZODONE [INN],Lopac0_001159,19794-93-5,Trazodil,Spectrum_001424,NCGC00016035-01,AB00053648_15, Trazodonum,2-(3-(4-(3-Chlorophenyl)piperazin-1-yl)propyl)-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one,2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one,BCP07176,GTPL213,NCGC00016035-25,1,2,4-Triazolo(4,3-a)pyridin-3(2H)-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-,Trialodine,Beneficat,Prestwick0_000292,TRAZODONE [MI], Trazodona,ZINC538483, Trazalon,YBK48BXK30,Prestwick1_000292,D08626,NCGC00016035-05, Trazodone (Desyrel), Trialodine,Trazodona, Trazodone [INN:BAN],BSPBio_000224,BRD-K70778732-003-05-1,NCGC00016035-09,UNII-YBK48BXK30,SPBio_002443,BRN 0628010, Desirel,NCGC00016035-03,CHEMBL621,Sideril,Trazodon, Desirel (TN),EINECS 243-317-1,2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one #,IDI1_000196,s-Triazolo(4,3-a)pyridin-3(2H)-one, 2-(3-(4-(m-chlorophenyl)-1-piperazinyl)propyl)-,Trazodona [INN-Spanish], Desyrel(trazodone hcl salt), Trazodona [INN-Spanish],EC 243-317-1, Trialodine (TN), 2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one,BRD-K70778732-003-15-0,SPBio_000867,Spectrum4_000755,Trittico, Trazodona [Spanish],SDCCGSBI-0051126.P004,CHEBI:9654,NCGC00016035-02,Trazodonum,NCGC00016035-07,AB00053648-14, Trazolan,NCGC00016035-08,EN300-708789,AMY32533,Lopac-T-6154,J10.767K

Estimated data

Solubilidad: -3.621 (log(S) in mol/L prediction using SolTranNet)

Addictivity Prediction: 45.6% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.